NCT00362726 - Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

HIV Infections

Interventions

DRUG

Rosiglitazone maleate

Tablets, Oral, RGZ 4 mg, once daily, 1 day.

DRUG

Atazanavir Sulphate

Capsules, Oral, ATV 400 mg, once daily, 5 days.

DRUG

Atazanavir Sulphate + Rosiglitazone maleate

Capsule, Oral, ATV 400 mg + RGZ 4 mg, once daily, 1 day.

DRUG

Atazanavir Sulphate + Ritonavir

Capsules, Oral, ATV 300 mg + RTV 100 mg, once daily, 14 days.

DRUG

Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate

Capsules/Tablets, Oral, ATV 300 mg + RTV 100 mg + RGZ 4 mg, once daily, 1 day.

Trial Locations (1)

Local Institution, Hamilton